AP3B1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.300200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.784200E-01
Normal-vs-Stage2
7.117800E-01
Normal-vs-Stage3
1.771380E-01
Normal-vs-Stage4
4.287800E-01
Stage1-vs-Stage2
4.393000E-01
Stage1-vs-Stage3
1.162020E-01
Stage1-vs-Stage4
5.180000E-01
Stage2-vs-Stage3
1.338430E-01
Stage2-vs-Stage4
1.482570E-01
Stage3-vs-Stage4
3.977700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.171800E-01
Normal-vs-AfricanAmerican
8.418000E-01
Normal-vs-Asian
4.108400E-01
Caucasian-vs-AfricanAmerican
3.569000E-01
Caucasian-vs-Asian
1.461790E-01
AfricanAmerican-vs-Asian
2.156000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.358600E-01
Normal-vs-Female
7.287000E-01
Male-vs-Female
8.896600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.002400E-01
Normal-vs-Age(41-60Yrs)
9.953600E-01
Normal-vs-Age(61-80Yrs)
6.231400E-01
Normal-vs-Age(81-100Yrs)
6.609400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.924770E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.894000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.869000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.313600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.525800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.648000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.795200E-01
Normal-vs-Daily Drinker
3.391200E-01
Normal-vs-Weekly Drinker
4.323000E-01
Normal-vs-Occasional Drinker
9.331000E-01
Normal-vs-Social Drinker
9.562400E-01
Non Drinker-vs-Daily Drinker
8.830800E-01
Non Drinker-vs-Weekly Drinker
9.543400E-01
Non Drinker-vs-Occasional Drinker
5.982500E-02
Non Drinker-vs-Social Drinker
1.394790E-01
Daily Drinker-vs-Weekly Drinker
9.508800E-01
Daily Drinker-vs-Occasional Drinker
5.561700E-02
Daily Drinker-vs-Social Drinker
1.270440E-01
Weekly Drinker-vs-Occasional Drinker
1.226800E-01
Weekly Drinker-vs-Social Drinker
2.219200E-01
Occasional Drinker-vs-Social Drinker
8.078200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.230500E-02
Normal-vs-Grade 2
1.121890E-02
Normal-vs-Grade 3
6.758100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.454980E-01
Grade 1-vs-Grade 3
1.015600E-01
Grade 1-vs-Grade 4
5.230500E-02
Grade 2-vs-Grade 3
7.044000E-01
Grade 2-vs-Grade 4
1.121890E-02
Grade 3-vs-Grade 4
6.758100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.683800E-01
Normal-vs-NonDiabetic
5.902800E-01
Diabetic-vs-NonDiabetic
9.144400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.565000E-01
Normal-vs-NoPancreatitis
6.621600E-01
Pancreatitis-vs-NoPancreatitis
3.833600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.186600E-01
Normal-vs-N1
7.213800E-01
N0-vs-N1
6.924000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.372600E-01
Normal-vs-TP53-NonMutant
9.935000E-01
TP53-Mutant-vs-TP53-NonMutant
8.215200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
